@article{oai:soar-ir.repo.nii.ac.jp:00003894,
 author = {Tazawa,  Ko-Ichi and Katoh,  Nagaaki and Shimojima,  Yasuhiro and Matsuda,  Masayuki and Ikeda,  Shu-ichi},
 issue = {3},
 journal = {AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS},
 month = {},
 note = {This is an electronic version of an article published in Amyloid 2009, Vol. 16, No. 3 : Pages 183-185. Amyloid is available online at: http://informahealthcare.com/doi/pdf/10.1080/13506120903151825, A male patient with primary AL amyloidosis who had been suffering from systemic lymphadenopathy with IgM kappa-type M-proteinemia received two courses of VAD and high-dose melphalan with in vivo elimination of CD20(+) cells using rituximab followed by autologous peripheral blood stem cell transplantation. Four years after complete hematological remission he showed marked reduction in size of the amyloid-laden lymph nodes. Deposits of AL amyloid may regress from the tissue if the chemotherapy succeeds in persistent inhibition of the production of amyloidogenic immunoglobulin light chains., Article, AMYLOID. 16(3):183-185 (2009)},
 pages = {183--185},
 title = {Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis},
 volume = {16},
 year = {2009}
}